UNIVERSITY OF ROCHESTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Clinical Trials
680
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (558 trials with phase data)• Click on a phase to view related trials
Advancing Smoking Cessation Among Transgender
- Conditions
- Smoking Cessation
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 40
- Registration Number
- NCT07099287
- Locations
- 🇦🇷
Fundación Huésped, Buenos Aires, Argentina
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
- Conditions
- Duchenne Muscular Dystrophy (DMD)
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 105
- Registration Number
- NCT07092540
Calcium Channel Blocker in Myotonic Dystrophy Type 1
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 20
- Registration Number
- NCT07075965
Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
- Conditions
- Incontinence, Urinary StressProstate CancerBenign Prostate Hyperplasia
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 132
- Registration Number
- NCT07071207
- Locations
- 🇺🇸
158 Sawgrass clinic; Suite 3100, Rochester, New York, United States
Tumor-Lymph Node Mapping
- Conditions
- Pediatric Solid TumorsRhabdomyosarcomaSarcomaGerm Cell Tumor
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 10
- Registration Number
- NCT07054944
- Prev
- 1
- 2
- 3
- 4
- 5
- 136
- Next
News
Genflow Biosciences Advances SIRT6 Patent Applications in Europe and Japan for Age-Related Disease Therapies
Genflow Biosciences has successfully progressed its SIRT6 variant patent application through the European Patent Office's Supplementary Search Report without additional questions, strengthening its intellectual property position.
PhotoPharmics Reaches 50% Enrollment Milestone in Phase 3 Trial Testing Light Therapy for Parkinson's Disease
PhotoPharmics has enrolled 150 participants in its Light for PD Phase 3 clinical trial, evaluating specialized phototherapy for both motor and non-motor symptoms of Parkinson's disease.
Financial Toxicity Remains Major Barrier in Cancer Care Despite Improved Patient Experience
Recent data shows significant gender disparity in cancer care, with 31% of women and 21% of men reporting their initial health concerns were not taken seriously by healthcare providers.